Skip to main content

Want a detailed portfolio tracker?

Kiniksa Pharmaceuticals International (KNSA) Income Statement (2017 - 2026)

Income Statement report data from Jun 30, 2017 to Mar 31, 2026 for Kiniksa Pharmaceuticals International (KNSA).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017
Revenue and COGS
Total Revenue
214M
(+6.01%)
202M
(+11.76%)
181M
(+15.34%)
157M
(+13.80%)
138M
(+12.44%)
123M
(+9.21%)
112M
(+3.30%)
109M
(+36.03%)
80M
(-4.24%)
83M
(+24.38%)
67M
(-6.18%)
71M
(+47.82%)
48M
(-21.86%)
62M
(-37.58%)
99M
(+267.59%)
27M
(-16.22%)
32M
(+71.68%)
19M
(+54.96%)
12M
(+57.14%)
7.70M---------------
Operating Expenses
Research And Development
27M
(-20.60%)
35M
(+43.19%)
24M
(+28.91%)
19M
(-3.00%)
19M
(-45.12%)
35M
(+35.15%)
26M
(+8.49%)
24M
(-8.77%)
26M
(+31.32%)
20M
(+17.18%)
17M
(-28.02%)
24M
(+56.69%)
15M
(+5.42%)
14M
(-12.73%)
16M
(+19.49%)
14M
(-33.72%)
21M
(-24.10%)
27M
(+42.57%)
19M
(-19.67%)
24M
(-16.49%)
29M
(-23.32%)
37M
(+19.03%)
31M
(+40.77%)
22M
(+6.79%)
21M
(-8.69%)
23M
(+4.00%)
22M
(-28.65%)
31M
(-47.93%)
59M
(+64.04%)
36M
(+75.00%)
21M
(+20.00%)
17M
(+36.18%)
13M
(-9.85%)
14M
(+51.13%)
9.27M
Selling General And Administrative
61M
(+7.70%)
57M
(+15.64%)
49M
(+4.78%)
47M
(+7.65%)
44M
(+7.40%)
41M
(-12.65%)
46M
(+9.43%)
42M
(+9.62%)
39M
(+5.28%)
37M
(+6.59%)
34M
(+18.13%)
29M
(+0.45%)
29M
(+6.72%)
27M
(+10.29%)
25M
(+3.52%)
24M
(+7.29%)
22M
(-2.29%)
23M
(+9.54%)
21M
(-4.99%)
22M
(+6.07%)
21M
(+32.90%)
16M
(+31.36%)
12M
(+23.69%)
9.54M
(+12.37%)
8.49M
(-12.47%)
9.70M
(+15.07%)
8.43M
(-0.12%)
8.44M
(+0.60%)
8.39M
(+4.74%)
8.01M
(+45.11%)
5.52M
(+27.48%)
4.33M
(+16.71%)
3.71M
(+65.63%)
2.24M
(+5.66%)
2.12M
Operating Expenses
89M
(-3.01%)
91M
(+24.72%)
73M
(+11.66%)
66M
(+4.39%)
63M
(-17.02%)
76M
(+4.54%)
72M
(+9.11%)
66M
(+2.14%)
65M
(+14.49%)
57M
(+10.12%)
52M
(-2.59%)
53M
(+19.72%)
44M
(+6.27%)
42M
(+1.09%)
41M
(+9.35%)
38M
(-12.55%)
43M
(-14.21%)
50M
(+25.46%)
40M
(-12.67%)
46M
(-7.08%)
49M
(-6.84%)
53M
(+22.40%)
43M
(+35.66%)
32M
(+8.40%)
29M
(-9.79%)
33M
(+7.00%)
30M
(-22.50%)
39M
(-41.92%)
68M
(+53.30%)
44M
(+68.69%)
26M
(+21.50%)
22M
(+31.76%)
16M
(+0.55%)
16M
(+42.67%)
11M
Depreciation And Amortization
470K
(-59.83%)
1.17M
(+3800.00%)
30K
(+200.00%)
10K
(-97.14%)
350K
(-65.69%)
1.02M
(+1033.33%)
90K
(-25.00%)
120K
(-74.47%)
470K
(-59.48%)
1.16M
(+300.00%)
290K
(0.00%)
290K
(-51.67%)
600K
(-50.82%)
1.22M
(+577.78%)
180K
(-48.57%)
350K
(-46.97%)
660K
(-47.20%)
1.25M
(+237.84%)
370K
(-11.90%)
420K
(+35.48%)
310K
(-45.61%)
570K
(-12.31%)
650K
(+8.33%)
600K
(+1.69%)
590K
(+3.51%)
570K
(+9.62%)
520K
(+1.96%)
510K
(+8.51%)
470K
(+88.00%)
250K
(+2400.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
Operating Income
Operating Income
29M
(+48.05%)
20M
(-17.69%)
24M
(+19.15%)
20M
(+51.92%)
13M-19.30M
(+99.79%)
-9.66M
(+7950.00%)
-120.00K
(-99.27%)
-16.54M80K-10.93M
(+246.98%)
-3.15M
(-71.88%)
-11.20M6.05M
(-86.96%)
46M-19.37M
(-16.94%)
-23.32M
(-35.46%)
-36.13M
(+17.80%)
-30.67M
(-24.36%)
-40.55M
(-17.72%)
-49.28M
(-6.84%)
-52.90M
(+22.40%)
-43.22M
(+35.66%)
-31.86M
(+8.40%)
-29.39M
(-9.79%)
-32.58M
(+7.00%)
-30.45M
(-22.50%)
-39.29M
(-41.92%)
-67.65M
(+53.30%)
-44.13M
(+68.69%)
-26.16M
(+21.50%)
-21.53M
(+31.76%)
-16.34M
(+0.55%)
-16.25M
(+42.67%)
-11.39M
Ebit
29M
(+48.05%)
20M
(-17.69%)
24M
(+19.15%)
20M
(+51.92%)
13M-19.30M
(+99.79%)
-9.66M
(+7950.00%)
-120.00K
(-99.27%)
-16.54M80K-10.93M
(+246.98%)
-3.15M
(-71.88%)
-11.20M6.05M
(-86.96%)
46M-19.37M
(-16.94%)
-23.32M
(-35.46%)
-36.13M
(+17.80%)
-30.67M
(-24.36%)
-40.55M
(-17.72%)
-49.28M
(-6.84%)
-52.90M
(+22.40%)
-43.22M
(+35.66%)
-31.86M
(+8.40%)
-29.39M
(-9.79%)
-32.58M
(+7.00%)
-30.45M
(-22.50%)
-39.29M
(-41.92%)
-67.65M
(+53.30%)
-44.13M
(+68.69%)
-26.16M
(+21.50%)
-21.53M
(+31.76%)
-16.34M
(+0.55%)
-16.25M
(+42.67%)
-11.39M
EBITDA
30M
(+42.02%)
21M
(-12.93%)
24M
(+19.24%)
20M
(+48.09%)
14M-18.28M
(+91.01%)
-9.57M--16.08M1.24M-10.63M
(+271.68%)
-2.86M
(-73.02%)
-10.60M7.27M
(-84.40%)
47M-19.02M
(-16.06%)
-22.66M
(-35.03%)
-34.88M
(+15.15%)
-30.29M
(-24.54%)
-40.14M
(-18.03%)
-48.97M
(-6.42%)
-52.33M
(+22.93%)
-42.57M
(+36.18%)
-31.26M
(+8.58%)
-28.79M
(-10.06%)
-32.01M
(+6.99%)
-29.92M
(-22.85%)
-38.78M
(-42.27%)
-67.18M
(+53.10%)
-43.88M
(+67.80%)
-26.15M
(+21.57%)
-21.51M
(+31.72%)
-16.33M
(+0.55%)
-16.24M
(+42.58%)
-11.39M
Other Income / Expenses
Interest Income
-12M---9.04M---8.23M---770K
(+140.63%)
320K
(+220.00%)
100K
(+233.33%)
30K
(-62.50%)
80K
(+700.00%)
10K
(0.00%)
10K
(0.00%)
10K
(-66.67%)
30K
(-40.00%)
50K
(-81.48%)
270K
(-65.82%)
790K
(-30.09%)
1.13M
(-18.71%)
1.39M
(-19.19%)
1.72M
(-4.97%)
1.81M
(+4.62%)
1.73M
(+6.79%)
1.62M
(+51.40%)
1.07M
(+245.16%)
310K
(+82.35%)
170K
(+13.33%)
150K
Net Interest Income
-12M---9.04M---8.23M---770K
(+140.63%)
320K
(+220.00%)
100K
(+233.33%)
30K
(-62.50%)
80K
(+700.00%)
10K
(0.00%)
10K
(0.00%)
10K
(-66.67%)
30K
(-40.00%)
50K
(-81.48%)
270K
(-65.82%)
790K
(-30.09%)
1.13M
(-18.71%)
1.39M
(-19.19%)
1.72M
(-4.97%)
1.81M
(+4.62%)
1.73M
(+6.79%)
1.62M
(+51.40%)
1.07M
(+245.16%)
310K
(+82.35%)
170K
(+13.33%)
150K
Net Income
Income Before Tax
33M
(+40.44%)
23M
(-14.32%)
27M
(+18.71%)
23M
(+46.95%)
16M-16.98M
(+135.83%)
-7.20M2.30M-14.28M2.45M-8.50M
(+585.48%)
-1.24M
(-86.75%)
-9.36M6.84M
(-85.37%)
47M-19.26M
(-17.27%)
-23.28M
(-35.42%)
-36.05M
(+17.58%)
-30.66M
(-24.39%)
-40.55M
(-17.70%)
-49.27M
(-6.81%)
-52.87M
(+22.47%)
-43.17M
(+36.66%)
-31.59M
(+10.45%)
-28.60M
(-9.06%)
-31.45M
(+8.22%)
-29.06M
(-22.63%)
-37.56M
(-42.95%)
-65.84M
(+55.25%)
-42.41M
(+72.82%)
-24.54M
(+19.94%)
-20.46M
(+27.64%)
-16.03M
(-0.31%)
-16.08M
(+43.06%)
-11.24M
Income Tax Expense
10M
(+11.25%)
9.07M
(+4.01%)
8.72M
(+72.67%)
5.05M
(-28.17%)
7.03M-8.09M5.49M
(-11.59%)
6.21M
(+81.05%)
3.43M-22.79M5.36M-16.21M2.91M
(+22.27%)
2.38M-177.36M720K
(-62.69%)
1.93M
(+589.29%)
280K-120.00K1.01M
(+380.95%)
210K
(-73.42%)
790K
(+17.91%)
670K
(-88.61%)
5.88M-2.18M350K-2.00M
(+440.54%)
-370.00K
(+1750.00%)
-20.00K170K-130.00K
(-35.00%)
-200.00K
(+300.00%)
-50.00K
(0.00%)
-50.00K
(+25.00%)
-40.00K
Net Income From Continuing Operations
23M
(+59.08%)
14M
(-22.95%)
18M
(+3.37%)
18M
(+108.78%)
8.54M-8.89M
(-29.94%)
-12.69M
(+224.55%)
-3.91M
(-77.91%)
-17.70M25M-13.85M15M-12.27M4.46M
(-98.01%)
224M-19.98M
(-20.75%)
-25.21M
(-30.61%)
-36.33M
(+18.96%)
-30.54M
(-26.52%)
-41.56M
(-16.01%)
-49.48M
(-7.79%)
-53.66M
(+22.40%)
-43.84M
(+17.00%)
-37.47M
(+41.82%)
-26.42M
(-16.92%)
-31.80M
(+17.52%)
-27.06M
(-27.24%)
-37.19M
(-43.50%)
-65.82M
(+54.58%)
-42.58M
(+74.44%)
-24.41M
(+20.48%)
-20.26M
(+26.78%)
-15.98M
(-0.31%)
-16.03M
(+43.13%)
-11.20M
Net Income
23M
(+59.08%)
14M
(-22.95%)
18M
(+3.37%)
18M
(+108.78%)
8.54M-8.89M
(-29.94%)
-12.69M
(+224.55%)
-3.91M
(-77.91%)
-17.70M25M-13.85M15M-12.27M4.46M
(-98.01%)
224M-19.98M
(-20.75%)
-25.21M
(-30.61%)
-36.33M
(+18.96%)
-30.54M
(-26.52%)
-41.56M
(-16.01%)
-49.48M
(-7.79%)
-53.66M
(+22.40%)
-43.84M
(+17.00%)
-37.47M
(+41.82%)
-26.42M
(-16.92%)
-31.80M
(+17.52%)
-27.06M
(-27.24%)
-37.19M
(-43.50%)
-65.82M
(+54.58%)
-42.58M
(+74.44%)
-24.41M
(+20.48%)
-20.26M
(+26.78%)
-15.98M
(-0.31%)
-16.03M
(+43.13%)
-11.20M
Comprehensive Income Net Of Tax
22M
(-62.88%)
59M
(+222.64%)
18M
(+2.17%)
18M
(+110.07%)
8.54M-43.36M
(+244.13%)
-12.60M
(+216.58%)
-3.98M
(-77.59%)
-17.76M14M-13.87M15M-12.26M183M
(-18.13%)
224M-19.97M
(-20.91%)
-25.25M
(-84.01%)
-157.96M
(+415.87%)
-30.62M
(-26.23%)
-41.51M
(-16.09%)
-49.47M
(-69.36%)
-161.45M
(+268.27%)
-43.84M
(+16.29%)
-37.70M
(+43.84%)
-26.21M
(-83.80%)
-161.83M
(+497.16%)
-27.10M
(-26.95%)
-37.10M
(-43.63%)
-65.81M
(-36.25%)
-103.23M
(+322.90%)
-24.41M
(+20.48%)
-20.26M
(+26.78%)
-15.98M--